Schedule 13G ownership disclosure

Intellipharmaceutics International Inc.

Security class unavailable · CUSIP: 458173309

Event date: 2018-11-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,290,604
Percent of class
9.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000062
Form type
SC 13G
Filer
Intellipharmaceutics International Inc.
CIK
CIK 1474835
Filed
Jan 29, 2019
Reporting period
Nov 27, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub